Summit Therapeutics Inc. financial data

Symbol
SMMT on Nasdaq
Location
Miami, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 20 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 669% % 39%
Debt-to-equity 19% % -70%
Return On Equity -311% % -199%
Return On Assets -262% % -308%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 744,442,538 shares 0.95%
Common Stock, Shares, Outstanding 744,442,533 shares 1%
Entity Public Float $827,300,000 USD 663%
Common Stock, Value, Issued $7,444,000 USD 0.99%
Weighted Average Number of Shares Outstanding, Basic 743,415,917 shares 2.3%
Weighted Average Number of Shares Outstanding, Diluted 743,415,917 shares 2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD
Research and Development Expense $80,461,000 USD 95%
General and Administrative Expense $493,662,000 USD 758%
Operating Income (Loss) $225,998,000 USD 63%
Nonoperating Income (Expense) $13,505,000 USD -46%
Net Income (Loss) Attributable to Parent $921,617,000 USD -369%
Earnings Per Share, Basic -1 USD/shares -577%
Earnings Per Share, Diluted -1 USD/shares -577%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $238,554,000 USD 154%
Assets, Current $246,466,000 USD -50%
Property, Plant and Equipment, Net $810,000 USD 206%
Operating Lease, Right-of-Use Asset $5,420,000 USD -32%
Intangible Assets, Net (Excluding Goodwill) $0 USD
Goodwill $1,999,000 USD 0.4%
Other Assets, Noncurrent $7,034,000 USD 278%
Assets $261,729,000 USD -48%
Accounts Payable, Current $22,245,000 USD 584%
Employee-related Liabilities, Current $10,965,000 USD 38%
Accrued Liabilities, Current $27,042,000 USD 46%
Liabilities, Current $64,928,000 USD 10%
Operating Lease, Liability, Noncurrent $2,708,000 USD -36%
Other Liabilities, Noncurrent $1,830,000 USD 6.6%
Liabilities $69,466,000 USD 7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,709,000 USD -17%
Retained Earnings (Accumulated Deficit) $2,074,987,000 USD -80%
Stockholders' Equity Attributable to Parent $192,263,000 USD -56%
Liabilities and Equity $261,729,000 USD -48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $61,168,000 USD -103%
Net Cash Provided by (Used in) Financing Activities $7,677,000 USD 1483%
Net Cash Provided by (Used in) Investing Activities $160,110,000 USD 706%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 744,442,533 shares 1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $106,657,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $238,875,000 USD 154%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $95,588,000 USD 13%
Deferred Tax Assets, Gross $95,925,000 USD 13%
Operating Lease, Liability $7,218,000 USD 18%
Depreciation $25,000 USD -7.4%
Payments to Acquire Property, Plant, and Equipment $422,000 USD 10450%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $922,118,000 USD -369%
Lessee, Operating Lease, Liability, to be Paid $7,984,000 USD 21%
Property, Plant and Equipment, Gross $1,372,000 USD 10%
Operating Lease, Liability, Current $2,720,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,809,000 USD -37%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,800,000 USD 35%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $766,000 USD 56%
Lessee, Operating Lease, Liability, to be Paid, Year Three $946,000 USD 5.9%
Deferred Tax Assets, Operating Loss Carryforwards $59,413,000 USD 0.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $2,122,000 USD 99%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,063,000 USD
Additional Paid in Capital $2,262,515,000 USD 43%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $631,656,000 USD 1197%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%